Pharma marketing is moving into the clinical workflow. As digital tools embed messaging across exams, telehealth, and pharmacies, brands can shape decisions in the moment—if they balance personalization with compliance and measurable results.

Spending on prescription drugs in the US grew 11.4% last year: IQVIA projects spending to keep increasing through 2029. Lowering Rx costs is emerging as a key priority for the Trump admin—much to the dismay of pharma.

Investor enthusiasm, AI tie-ups stand out at JP Morgan Healthcare Conference: We expect future investment activity to be driven by the AI arms race taking place across the healthcare and pharma industries.

Bad actors flood the GLP-1 weight loss drug market: Until the cost of branded GLP-1s drops, illegal online pharmacies advertising falsified versions of the drugs will keep lingering.

Activist investor takes $1B stake in Pfizer, eyes a performance turnaround: But to the drugmaker’s credit, its plan to diversify the therapeutic areas it will focus on moving forward should place it in line with investors’ expectations.

Dozens of digital pharmacies have appeared in recent years, jostling for consumers’ attention alongside the digital twins of national retail chains and mass merchandisers. The threat of recession may send more consumers online, looking for lower prescription prices.